CliffBio
small molecule

KETAMINE HYDROCHLORIDE

KETAMINE HYDROCHLORIDE

Loss of exclusivity—loss of exclusivity
CompanyBaxter Healthcare Corp →See this company's full patent-cliff portfolio

Drug detail

Brand nameKETAMINE HYDROCHLORIDE
Active ingredientKETAMINE HYDROCHLORIDE
StrengthEQ 100MG BASE/10ML (EQ 10MG BASE/ML)
Dosage formSOLUTION
RouteINTRAMUSCULAR, INTRAVENOUS
ModalitySmall molecule
FDA approvalSeptember 2025
Marketing statusDISCN

More from Baxter Healthcare Corp

Source: FDA Orange Book, layered on the CliffBio company graph. Cliff dates are the loss of exclusivity; estimates are projections, not legal advice.